Quelles sont les heures d'ouverture ?

Lundi 8am - 6pm Mardi 8am - 6pm Mercredi 8am - 6pm Jeudi 8am - 6pm Vendredi 8am - 6pm

CellCarta

Name: CellCarta
Address: 201 President Kennedy Avenue , Suite 3900, Montreal, QC, H2X3Y7, CA
Telephone: +15143603600
Price range: $$

Appeler Itinéraire Site Web Contacter l'entreprise

CellCarta, formely Caprion-HistoGenex CellCarta, formely Caprion-HistoGeneX.

CellCarta is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late stage clinical trials. The company operates globally with 9 facilities located in Canada, USA, Belgium, Australia, and China.

10/22/2026

Let's Talk! In our latest webcast, we discuss the realities of building and commercializing CAR-T therapies with Dr. John Rossi, a leader in the field of CAR-T therapy.

Christopher Ung, our Chief Scientific Business Officer, sat down with Dr. John Rossi, for a conversation ranging from the academic discovery that started the CAR-T field to where in vivo delivery, RNA-based platforms, and standardized biomarkers are headed next.

Dr. John Rossi built the biomarker program behind the first approved CAR-T therapies at Kite Pharma and later led translational medicine at Capstan Therapeutics, which was acquired by AbbVie for $2.1B in 2025.

Watch the full conversation here: https://buff.ly/IrpFOC6

10/21/2026

📌 Global Expertise + Local Presence
We're thrilled to be at AusBiotech this week - visit Pierre Gontard and Kevin Lo at Booth 118 in Gold Coast!

Drop by to discuss how we can support your local programs and global trials with our site in Sydney, global labs and expertise across immune monitoring, histopathology, genomics and proteomics, supported by comprehensive logistics.

See you at Booth 118 👋

10/20/2026

We're proud to be one of four CROs, along with BMS, who were invited by Sarah Hersey, BMS and Johnston Cancer Research Centre, to contribute de-identified data to this recent publication on the importance of regulatory submissions to clinical trial timelines.

Congratulations to the teams who made this important research possible, including the authors, contributors such as CellCarta's Pamela Swatkowski and Cassidy Turner, and other real-world data providers.

Read the full publication in the European Journal of Cancer here: https://buff.ly/6Mj7Glm

10/20/2026

Gold Coast! We're excited to be heading to AusBiotech - come meet us at Booth 118, from October 21 to 23.

Bring your biomarker questions - from multi-modal global trials to keeping your immunology testing local in Australia, our experts Pierre Gontard and Kevin Lo are excited to discuss how we can support your programs.

10/16/2026

Announcement! CellCarta and Tivenix are expanding their strategic partnership.

Tivenix's AI-powered platform applies bioinformatics to the epigenetic analysis of cell-free DNA and other tissue-derived signals, supporting early detection, patient stratification, and broader precision medicine applications. It starts with neurodegenerative conditions and is designed to extend across therapeutic areas.

Read the full announcement: https://buff.ly/uXMZVuG

10/14/2026

Did we miss you in Basel? We're still available to chat! 👋

The CellCarta team spent the week at Biomarkers, CDx and Precision Medicine, sharing our workflows for sequencing in challenging samples and high sensitivity B cell monitoring for autoimmune programs.

We're always excited to discuss the biggest challenges facing your programs, from translational research to CDx commercialization. If we missed you in Basel, send us a message to connect ✉️ https://buff.ly/0gMp5PK

10/13/2026

What a strong start to our week in Basel, with in depth explorations of B cell enumeration in autoimmunity, and whole transcriptome and exome sequencing in challenging clinical samples.

The conversations continue tomorrow, with Todd Chermak moderating a conversation in the NextGen Omics stream on how we build the precision diagnostics of the future.
Join him at 13:00 on October 14th!

We look forward to continuing the discussions at Booth #10 at Biomarkers, CDx and Precision Medicine!

10/09/2026

The biomarker discussions continue next week, as our experts head to Basel for Biomarkers, CDx and Precision Medicine Europe, and NextGen Omics Tech and Data.

Join us for discussions on high sensitivity B cell monitoring for autoimmune programs, managing whole transcriptome sequencing in challenging clinical samples, and how we bring together biomarkers, spatial data and AI in the CDx of the future.

Don't miss the chance to discuss you programs with our presenters and panelists, and the wider CellCarta team at Booth #10! See you in Basel.

10/08/2026

It's the last, but not the least day of World CB & CDx, and we managed to bring together the full CellCarta crew for a quick photo before they headed to their panels, meetings and biomarker and CDx discussions.

Thanks to our partners, including Global Digital Pathology Consortium members Mindpeak and Lunit Oncology who joined us for insightful conversations on how tissue AI analytics are changing the clinical biomarker game through digital pathology, as well as the organizers, Hanson Wade.

A special shout out to our Chief Scientific Business Officer, Christopher Ung, who spent a combined 7 hours presenting as conference chair, on panel discussions and in his own presentation on what we've learned about collaborative CDx models from our work in China!

10/08/2026

It's the last, but not the least day of World CB & CDx, and we managed to bring together the full CellCarta crew for a quick photo before they headed to their panels, meetings and biomarker and CDx discussions.

Thanks to our partners, including Global Digital Pathology Consortium members Mindpeak and Lunit Oncology who joined us for insightful conversations on how tissue AI analytics are changing the clinical biomarker game through digital pathology, and the organizers, Hanson Wade.

A special shout out to our Chief Scientific Business Officer, Christopher Ung, who spent a combined 7 hours presenting as conference chair, on panel discussions and in his own presentation on what we've learned about collaborative CDx models from our work in China.

Adresse

201 President Kennedy Avenue , Suite 3900
Montreal, QC
H2X3Y7

Heures d'ouverture

Lundi	8am - 6pm
Mardi	8am - 6pm
Mercredi	8am - 6pm
Jeudi	8am - 6pm
Vendredi	8am - 6pm

Téléphone

+15143603600

Site Web

https://cellcarta.com/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque CellCarta publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.